John A Ambrose, MD
Cardiovascular Disease (Cardiology) · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 54 years
- Graduated 1972
Offices
2 locations · Central California Faculty Medical Group Inc · Fresno Community Hospital and Medical Center
Looking this up.
Hospitals listed: Adventist Health Hanford · Clovis Community Medical Center · Community Regional Medical Center · Kaweah Health Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ambrose’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G87536 · Current
Licensed to practise in California · since 2005 · expires 2028-09-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health HanfordHanford, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.277, Oct 2024 – Sep 2025
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Kaweah Health Medical CenterVisalia, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Kaweah Delta Health Care DistrictPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 239.86 (194.11 to 285.6) · 104 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Hanford
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 614 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.38 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.5 (130.11 to 250.89) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 269 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,486 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,819 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.67 (0.36 to 4.98) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 154 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.02 to 4.28) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.19) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 3,186 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 38 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.5 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10 to 17) · 896 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 228 cases | No different | Jan 2024 – Dec 2024 |
What patients said (947 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Kaweah Health Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 3 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 239.86 (194.11 to 285.6) · 104 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.22 (0.28 to 2.16) · 1,600 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.53 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 145 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.8 · 626 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.1 · 741 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 373 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,927 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,045 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.38) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.81 to 5.63) · 2,251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.53 to 3.61) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.79 (0.45 to 3.13) · 2,231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.88 (1.1 to 12.66) · 799 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.59 (0 to 7.19) · 759 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 416 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 0.89) · 8,159 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 43 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.728 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.405 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.023 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.551 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 344 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 799 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17 · 286 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 31.4 · 686 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -6 · 734 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 776 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.6 to 7.6) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.9 (6.6 to 11.9) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 317 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.3 to 14) · 1,748 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 680 cases | No different | Jan 2024 – Dec 2024 |
What patients said (435 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$74,494
Medicare paid this office $74,494 for 3,228 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,062 | $24,601 | $6 |
| Return visit (30+ min) | 102 | $15,607 | $96 |
| Long return visit (40+ min) | 45 | $8,396 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $7,615 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,233 | $92 |
See all 10 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,062 | $24,601 | $6 |
| Return visit (30+ min) | 102 | $15,607 | $96 |
| Long return visit (40+ min) | 45 | $8,396 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $7,615 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,233 | $92 |
| New patient visit (60+ min) | 19 | $2,710 | $143 |
| Short return visit (20+ min) | 37 | $2,661 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,155 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,031 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 64 | $813 | $11 |
Who their Medicare patients are
3,228 Original Medicare patients in 2024. Average age 73 · Under 65 14% · 85 and older 13% · Women 51% · Also on Medicaid 52% · Health risk score 2.42. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 54% · Coronary heart disease 50% · Chronic kidney disease 47% · Heart failure 42% · Atrial fibrillation 31% · Depression 29% · COPD 25% · Stroke 18% · Cancer 16% · Dementia 16%.
The office billed $611,989, Medicare allowed $99,860 and paid $74,494; for 4,704 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 3,228 | 4,704 | 73 | 2.42 | $611,989 | $74,494 |
| 2023 | 3,751 | 5,209 | 73 | 2.22 | $642,383 | $67,458 |
| 2022 | 3,663 | 5,382 | 72 | 2.16 | $684,428 | $85,408 |
| 2021 | 3,625 | 5,862 | 73 | 2.29 | $737,511 | $91,143 |
| 2020 | 4,384 | 7,499 | 72 | 2.35 | $925,601 | $95,272 |
| 2019 | 4,181 | 6,836 | 72 | 2.43 | $861,560 | $93,978 |
| 2018 | 3,002 | 5,869 | 71 | 2.60 | $786,026 | $108,440 |
| 2017 | 2,527 | 4,727 | 71 | 2.65 | $652,618 | $92,387 |
| 2016 | 2,312 | 4,366 | 71 | 2.58 | $615,891 | $96,081 |
| 2015 | 1,976 | 3,690 | 71 | 2.49 | $566,302 | $103,883 |
| 2014 | 1,004 | 2,121 | 71 | 2.53 | $414,679 | $105,738 |
| 2013 | 860 | 2,070 | 72 | 2.48 | $357,424 | $94,306 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,588 | $28,813 | $6 |
| Return visit (30+ min) | 120 | $16,684 | $96 |
| Long return visit (40+ min) | 33 | $5,376 | $138 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,022 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,838 | $65 |
| New patient visit (60+ min) | 15 | $2,542 | $169 |
| Short return visit (20+ min) | 32 | $2,030 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,747 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 69 | $827 | $11 |
2022: 12 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,463 | $29,925 | $6 |
| Return visit (30+ min) | 119 | $18,402 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 66 | $7,028 | $106 |
| Long return visit (40+ min) | 34 | $5,525 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $4,761 | $82 |
| Short return visit (20+ min) | 52 | $4,077 | $65 |
| New patient visit (60+ min) | 21 | $3,377 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,403 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,155 | $144 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 92 | $1,178 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 13 | $304 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 13 | $106 | $7 |
2021: 10 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,431 | $33,237 | $6 |
| Return visit (30+ min) | 139 | $23,077 | $97 |
| Long return visit (40+ min) | 42 | $7,372 | $147 |
| Short return visit (20+ min) | 63 | $4,838 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,729 | $85 |
| New patient visit (60+ min) | 19 | $3,288 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,230 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,628 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,887 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 96 | $1,254 | $12 |
2020: 9 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 4,196 | $44,974 | $7 |
| Return visit (30+ min) | 131 | $14,504 | $75 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 57 | $6,231 | $109 |
| Long return visit (40+ min) | 54 | $5,959 | $99 |
| Short return visit (20+ min) | 71 | $5,763 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,418 | $60 |
| New patient visit (60+ min) | 20 | $3,323 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,623 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 93 | $1,309 | $12 |
2019: 9 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,979 | $40,181 | $7 |
| Return visit (30+ min) | 148 | $15,205 | $74 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 72 | $7,937 | $110 |
| Long return visit (40+ min) | 52 | $6,747 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $5,401 | $59 |
| New patient visit (60+ min) | 19 | $2,949 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,518 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 98 | $1,455 | $13 |
| Short return visit (20+ min) | 27 | $1,408 | $47 |
2018: 13 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 2,746 | $32,609 | $7 |
| Return visit (30+ min) | 167 | $18,913 | $75 |
| Long return visit (40+ min) | 66 | $9,302 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,196 | $164 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 52 | $6,287 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $5,914 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $4,896 | $58 |
| New patient visit (60+ min) | 24 | $3,859 | $161 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,492 | $208 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 101 | $1,537 | $13 |
| Short return visit (20+ min) | 26 | $1,444 | $53 |
| Long return visit (40+ min) | 12 | $1,167 | $90 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $452 | $17 |
2017: 14 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 2,268 | $26,068 | $7 |
| Return visit (30+ min) | 160 | $16,365 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $10,767 | $158 |
| Long return visit (40+ min) | 71 | $9,151 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,560 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,471 | $108 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,399 | $212 |
| New patient visit (60+ min) | 15 | $2,407 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,073 | $83 |
| Return visit (30+ min) | 26 | $1,812 | $62 |
| Short return visit (20+ min) | 27 | $1,537 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 61 | $684 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $397 | $15 |
| Short return visit (20+ min) | 11 | $364 | $33 |
2016: 13 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 2,060 | $23,132 | $7 |
| Return visit (30+ min) | 175 | $20,445 | $76 |
| Long return visit (40+ min) | 83 | $11,996 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,859 | $164 |
| New patient visit (60+ min) | 30 | $4,664 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,765 | $108 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,387 | $199 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 130 | $2,090 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,685 | $84 |
| Short return visit (20+ min) | 17 | $1,019 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $935 | $58 |
| Short return visit (20+ min) | 11 | $414 | $38 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $332 | $14 |
2015: 11 services
| Return visit (30+ min) | 175 | $18,926 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,715 | $18,181 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $13,292 | $162 |
| Long return visit (40+ min) | 81 | $12,740 | $110 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $5,025 | $209 |
| New patient visit (60+ min) | 29 | $4,823 | $166 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 167 | $3,200 | $13 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,999 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,281 | $84 |
| Short return visit (20+ min) | 11 | $655 | $60 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $328 | $16 |
2014: 11 services
| Return visit (30+ min) | 172 | $18,290 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $17,865 | $162 |
| Long return visit (40+ min) | 107 | $17,828 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 687 | $6,635 | $7 |
| New patient visit (60+ min) | 38 | $6,016 | $158 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 25 | $4,721 | $182 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,010 | $182 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 178 | $3,395 | $13 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,211 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,851 | $84 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $365 | $11 |
2013: 15 services
| Return visit (30+ min) | 177 | $25,209 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $12,247 | $157 |
| Long return visit (40+ min) | 62 | $9,747 | $112 |
| New patient visit (60+ min) | 38 | $6,027 | $159 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 578 | $5,210 | $6 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $4,114 | $217 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 173 | $3,558 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $3,009 | $158 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,470 | $107 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $1,642 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,641 | $82 |
| Short return visit (20+ min) | 27 | $1,331 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 18 | $955 | $50 |
| Programming of dual lead pacemaker system | 11 | $674 | $45 |
| Blood test, clotting time | 17 | $442 | $5 |
Medicaid work
$54,462 in 2024
Medicaid paid $54,462 for 6,669 billed services this clinician did in 2024, up to 507 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 121 | $44,142 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 6,414 | $9,905 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 27 | $280 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 12 | $134 |
| Return visit (30+ min) | 95 | $0 |
| 2024 | 6,669 | 5 | 507 | $54,462 |
| 2023 | 8,584 | 7 | 560 | $34,898 |
| 2022 | 6,659 | 3 | 456 | $35,434 |
| 2021 | 4,141 | 4 | 242 | $55,328 |
| 2020 | 2,904 | 2 | 123 | $28,012 |
| 2019 | 2,884 | 3 | 125 | $57,941 |
| 2018 | 7,196 | 6 | 405 | $41,114 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 67 | $23,541 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 8,369 | $10,667 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 15 | $352 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 14 | $189 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 16 | $82 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 19 | $34 |
| Return visit (30+ min) | 84 | $34 |
2022
| Clinic visit/encounter, all-inclusive | 101 | $30,642 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 6,519 | $4,792 |
| Return visit (30+ min) | 39 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 139 | $41,832 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3,926 | $12,957 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 25 | $539 |
| Return visit (30+ min) | 51 | $0 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,873 | $18,958 |
| Clinic visit/encounter, all-inclusive | 31 | $9,054 |
2019
| Clinic visit/encounter, all-inclusive | 183 | $42,208 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,674 | $15,732 |
| Short return visit (20+ min) | 27 | $0 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 6,204 | $25,125 |
| Clinic visit/encounter, all-inclusive | 53 | $11,652 |
| Long return visit (40+ min) | 880 | $3,491 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 15 | $465 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 19 | $212 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $169 |
Drugs they prescribed that Part D paid
$151,710
Pharmacies billed $151,710 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,168) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
980 generic and 188 brand-name prescriptions · $151,710 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 47 | $39,721 | $845 |
| Entresto | 25 | $34,536 | $1,381 |
| Jardiance | 41 | $31,293 | $763 |
| Xarelto | 16 | $18,539 | $1,159 |
| Vascepa | 11 | $4,851 | $441 |
See all 24 drugs
| Eliquis | 47 | $39,721 | $845 |
| Entresto | 25 | $34,536 | $1,381 |
| Jardiance | 41 | $31,293 | $763 |
| Xarelto | 16 | $18,539 | $1,159 |
| Vascepa | 11 | $4,851 | $441 |
| Metoprolol | 84 | $1,553 | $18 |
| Atorvastatin | 131 | $1,536 | $12 |
| Rosuvastatin | 112 | $1,397 | $12 |
| Ezetimibe | 48 | $1,148 | $24 |
| Nifedipine Er | 27 | $815 | $30 |
| Spironolactone | 59 | $640 | $11 |
| Losartan | 45 | $457 | $10 |
| Benazepril | 19 | $370 | $19 |
| Carvedilol | 53 | $355 | $7 |
| Clopidogrel | 19 | $348 | $18 |
| Amlodipine Besylate | 42 | $297 | $7 |
| Metoprolol | 43 | $284 | $7 |
| Nitroglycerin | 18 | $257 | $14 |
| Lisinopril | 48 | $223 | $5 |
| Furosemide | 63 | $210 | $3 |
| Simvastatin | 24 | $188 | $8 |
| Isosorbide Mononitrate Er | 21 | $172 | $8 |
| Hydrochlorothiazide | 58 | $99 | $2 |
| Losartan-Hydrochlorothiazide | 11 | $95 | $9 |
Year by year
| 2024 | 1,168 | 214 | 0% (0) | 16% | $151,710 |
| 2023 | 1,319 | 230 | 0% (0) | 11% | $167,678 |
| 2022 | 1,312 | 233 | 0% (0) | 11% | $145,216 |
| 2021 | 1,637 | 258 | 0% (0) | 13% | $159,888 |
| 2020 | 1,466 | 249 | None | 14% | $127,838 |
| 2019 | 1,823 | 253 | 0% (0) | 14% | $131,772 |
| 2018 | 2,053 | 263 | None | 14% | $108,621 |
| 2017 | 1,733 | 236 | 0% (0) | 17% | $83,809 |
| 2016 | 2,206 | 238 | 0% (0) | 19% | $108,479 |
| 2015 | 2,379 | 232 | None | 19% | $100,209 |
| 2014 | 2,865 | 252 | 0% (0) | 23% | $123,301 |
| 2013 | 2,763 | 271 | None | None | $133,763 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Eliquis | 62 | $53,584 | $864 |
| Xarelto | 24 | $25,706 | $1,071 |
| Entresto | 13 | $24,449 | $1,881 |
| Jardiance | 14 | $22,011 | $1,572 |
| Icosapent Ethyl | 12 | $5,786 | $482 |
| Atorvastatin | 195 | $3,806 | $20 |
| Ezetimibe | 57 | $3,297 | $58 |
| Rosuvastatin | 110 | $2,567 | $23 |
| Metoprolol | 108 | $2,234 | $21 |
| Eplerenone | 14 | $2,029 | $145 |
| Nifedipine Er | 28 | $1,860 | $66 |
| Lisinopril | 72 | $1,124 | $16 |
| Losartan | 73 | $878 | $12 |
| Spironolactone | 69 | $876 | $13 |
| Carvedilol | 60 | $747 | $12 |
| Metoprolol | 45 | $745 | $17 |
| Clopidogrel | 38 | $716 | $19 |
| Amlodipine Besylate | 38 | $627 | $16 |
| Furosemide | 56 | $489 | $9 |
| Isosorbide Mononitrate Er | 29 | $408 | $14 |
| Benazepril | 20 | $367 | $18 |
| Hydrochlorothiazide | 60 | $213 | $4 |
| Losartan-Hydrochlorothiazide | 15 | $93 | $6 |
2022: 25 drugs
| Eliquis | 51 | $40,370 | $792 |
| Xarelto | 30 | $32,686 | $1,090 |
| Entresto | 13 | $11,468 | $882 |
| Jardiance | 12 | $8,568 | $714 |
| Rosuvastatin | 96 | $5,842 | $61 |
| Ezetimibe | 57 | $5,431 | $95 |
| Icosapent Ethyl | 12 | $2,914 | $243 |
| Atorvastatin | 187 | $2,478 | $13 |
| Metoprolol | 99 | $2,038 | $21 |
| Eplerenone | 11 | $1,802 | $164 |
| Nifedipine Er | 33 | $1,450 | $44 |
| Losartan | 75 | $990 | $13 |
| Amlodipine Besylate | 56 | $797 | $14 |
| Lisinopril | 86 | $764 | $9 |
| Carvedilol | 33 | $445 | $13 |
| Furosemide | 68 | $423 | $6 |
| Clopidogrel | 31 | $407 | $13 |
| Bumetanide | 14 | $374 | $27 |
| Metoprolol | 46 | $297 | $6 |
| Spironolactone | 48 | $281 | $6 |
| Isosorbide Mononitrate Er | 23 | $272 | $12 |
| Amiodarone | 11 | $234 | $21 |
| Benazepril | 25 | $216 | $9 |
| Hydrochlorothiazide | 58 | $209 | $4 |
| Chlorthalidone | 16 | $198 | $12 |
2021: 26 drugs
| Eliquis | 66 | $59,340 | $899 |
| Xarelto | 27 | $27,545 | $1,020 |
| Entresto | 32 | $24,550 | $767 |
| Metoprolol | 149 | $4,542 | $30 |
| Ezetimibe | 49 | $4,070 | $83 |
| Atorvastatin | 241 | $3,691 | $15 |
| Rosuvastatin | 118 | $3,278 | $28 |
| Nifedipine Er | 68 | $1,902 | $28 |
| Losartan | 85 | $1,495 | $18 |
| Lisinopril | 95 | $939 | $10 |
| Bumetanide | 21 | $890 | $42 |
| Metoprolol | 52 | $589 | $11 |
| Furosemide | 105 | $561 | $5 |
| Amlodipine Besylate | 74 | $551 | $7 |
| Carvedilol | 43 | $533 | $12 |
| Spironolactone | 70 | $422 | $6 |
| Isosorbide Mononitrate Er | 29 | $408 | $14 |
| Fenofibrate | 11 | $355 | $32 |
| Clopidogrel | 22 | $333 | $15 |
| Warfarin | 13 | $316 | $24 |
| Nitroglycerin | 23 | $310 | $13 |
| Losartan-Hydrochlorothiazide | 15 | $308 | $21 |
| Hydrochlorothiazide | 63 | $264 | $4 |
| Benazepril | 34 | $217 | $6 |
| Lisinopril-Hydrochlorothiazide | 21 | $133 | $6 |
| Simvastatin | 13 | $118 | $9 |
2020: 27 drugs
| Eliquis | 49 | $35,981 | $734 |
| Entresto | 28 | $21,541 | $769 |
| Xarelto | 31 | $21,348 | $689 |
| Metoprolol | 164 | $4,803 | $29 |
| Atorvastatin | 228 | $4,456 | $20 |
| Ezetimibe | 27 | $3,892 | $144 |
| Rosuvastatin | 92 | $3,635 | $40 |
| Bystolic | 11 | $1,741 | $158 |
| Nifedipine Er | 53 | $1,666 | $31 |
| Losartan | 67 | $1,162 | $17 |
| Bumetanide | 12 | $913 | $76 |
| Isosorbide Mononitrate Er | 42 | $837 | $20 |
| Valsartan | 12 | $731 | $61 |
| Metoprolol | 60 | $702 | $12 |
| Losartan-Hydrochlorothiazide | 12 | $694 | $58 |
| Lisinopril | 95 | $598 | $6 |
| Carvedilol | 52 | $527 | $10 |
| Potassium Chloride | 16 | $453 | $28 |
| Clopidogrel | 25 | $425 | $17 |
| Furosemide | 57 | $384 | $7 |
| Amlodipine Besylate | 70 | $379 | $5 |
| Hydrochlorothiazide | 58 | $280 | $5 |
| Benazepril | 37 | $264 | $7 |
| Spironolactone | 21 | $180 | $9 |
| Nitroglycerin | 14 | $165 | $12 |
| Ramipril | 11 | $96 | $9 |
| Simvastatin | 15 | $88 | $6 |
2019: 29 drugs
| Eliquis | 105 | $55,446 | $528 |
| Xarelto | 33 | $25,323 | $767 |
| Metoprolol | 140 | $5,359 | $38 |
| Rosuvastatin | 98 | $5,105 | $52 |
| Atorvastatin | 261 | $4,939 | $19 |
| Brilinta | 11 | $4,719 | $429 |
| Nifedipine Er | 58 | $2,046 | $35 |
| Omega-3 Acid Ethyl Esters | 12 | $1,823 | $152 |
| Losartan | 151 | $1,731 | $11 |
| Isosorbide Mononitrate Er | 45 | $1,349 | $30 |
| Bumetanide | 19 | $1,034 | $54 |
| Carvedilol | 85 | $941 | $11 |
| Metoprolol | 118 | $824 | $7 |
| Valsartan | 12 | $781 | $65 |
| Ezetimibe | 16 | $753 | $47 |
| Lisinopril | 99 | $627 | $6 |
| Clopidogrel | 45 | $601 | $13 |
| Amlodipine Besylate | 80 | $562 | $7 |
| Hydrochlorothiazide | 91 | $536 | $6 |
| Warfarin | 21 | $519 | $25 |
| Potassium Chloride | 19 | $462 | $24 |
| Furosemide | 63 | $430 | $7 |
| Nitroglycerin | 15 | $301 | $20 |
| Losartan-Hydrochlorothiazide | 19 | $290 | $15 |
| Spironolactone | 36 | $255 | $7 |
| Ramipril | 12 | $236 | $20 |
| Benazepril | 33 | $227 | $7 |
| Lisinopril-Hydrochlorothiazide | 15 | $162 | $11 |
| Simvastatin | 14 | $136 | $10 |
2018: 30 drugs
| Eliquis | 55 | $29,544 | $537 |
| Xarelto | 45 | $24,488 | $544 |
| Pradaxa | 17 | $10,312 | $607 |
| Metoprolol | 160 | $7,113 | $44 |
| Atorvastatin | 259 | $4,630 | $18 |
| Rosuvastatin | 79 | $4,047 | $51 |
| Nifedipine Er | 58 | $2,352 | $41 |
| Losartan | 131 | $1,392 | $11 |
| Digoxin | 34 | $1,262 | $37 |
| Warfarin | 44 | $1,121 | $25 |
| Bumetanide | 19 | $1,060 | $56 |
| Metoprolol | 137 | $1,010 | $7 |
| Amlodipine Besylate | 120 | $878 | $7 |
| Potassium Chloride | 27 | $874 | $32 |
| Isosorbide Mononitrate Er | 48 | $818 | $17 |
| Lisinopril | 146 | $815 | $6 |
| Carvedilol | 96 | $736 | $8 |
| Valsartan | 19 | $731 | $38 |
| Clopidogrel | 29 | $586 | $20 |
| Digox | 11 | $493 | $45 |
| Hydrochlorothiazide | 101 | $475 | $5 |
| Furosemide | 75 | $438 | $6 |
| Losartan-Hydrochlorothiazide | 32 | $318 | $10 |
| Ramipril | 20 | $316 | $16 |
| Spironolactone | 50 | $311 | $6 |
| Sotalol | 12 | $305 | $25 |
| Benazepril | 48 | $301 | $6 |
| Nitroglycerin | 15 | $241 | $16 |
| Lisinopril-Hydrochlorothiazide | 27 | $201 | $7 |
| Simvastatin | 29 | $166 | $6 |
2017: 30 drugs
| Xarelto | 36 | $19,216 | $534 |
| Eliquis | 20 | $11,454 | $573 |
| Brilinta | 13 | $5,003 | $385 |
| Rosuvastatin | 64 | $4,896 | $76 |
| Metoprolol | 137 | $4,723 | $34 |
| Atorvastatin | 155 | $3,394 | $22 |
| Nifedipine Er | 53 | $2,088 | $39 |
| Digoxin | 27 | $1,483 | $55 |
| Valsartan | 24 | $1,401 | $58 |
| Warfarin | 58 | $1,247 | $21 |
| Metoprolol | 176 | $1,080 | $6 |
| Bumetanide | 14 | $820 | $59 |
| Losartan | 73 | $817 | $11 |
| Isosorbide Mononitrate Er | 29 | $787 | $27 |
| Potassium Chloride | 16 | $784 | $49 |
| Lisinopril | 144 | $654 | $5 |
| Digox | 11 | $593 | $54 |
| Carvedilol | 79 | $544 | $7 |
| Clopidogrel | 36 | $466 | $13 |
| Hydrochlorothiazide | 115 | $437 | $4 |
| Pravastatin | 13 | $432 | $33 |
| Furosemide | 87 | $414 | $5 |
| Ramipril | 25 | $406 | $16 |
| Benazepril | 46 | $344 | $7 |
| Sotalol | 12 | $291 | $24 |
| Losartan-Hydrochlorothiazide | 23 | $261 | $11 |
| Amlodipine Besylate | 62 | $232 | $4 |
| Simvastatin | 31 | $179 | $6 |
| Spironolactone | 15 | $144 | $10 |
| Diltiazem 24hr Er | 11 | $109 | $10 |
2016: 37 drugs
| Crestor | 48 | $20,062 | $418 |
| Xarelto | 47 | $17,249 | $367 |
| Pradaxa | 21 | $9,413 | $448 |
| Metoprolol | 174 | $5,691 | $33 |
| Eliquis | 14 | $5,632 | $402 |
| Atorvastatin | 174 | $3,709 | $21 |
| Nifedipine Er | 84 | $2,916 | $35 |
| Rosuvastatin | 30 | $2,671 | $89 |
| Digoxin | 48 | $2,044 | $43 |
| Omega-3 Acid Ethyl Esters | 12 | $1,457 | $121 |
| Digox | 27 | $1,386 | $51 |
| Warfarin | 83 | $1,349 | $16 |
| Isosorbide Mononitrate Er | 43 | $1,089 | $25 |
| Metoprolol | 171 | $1,088 | $6 |
| Valsartan | 29 | $1,088 | $38 |
| Losartan | 114 | $1,007 | $9 |
| Potassium Chloride | 29 | $983 | $34 |
| Lisinopril | 181 | $834 | $5 |
| Toprol Xl | 11 | $812 | $74 |
| Carvedilol | 114 | $746 | $7 |
| Clopidogrel | 60 | $715 | $12 |
| Nifedical Xl | 25 | $614 | $25 |
| Telmisartan | 11 | $569 | $52 |
| Bumetanide | 11 | $526 | $48 |
| Furosemide | 116 | $511 | $4 |
| Enalapril Maleate | 11 | $498 | $45 |
| Diltiazem 24hr Er | 19 | $489 | $26 |
| Hydrochlorothiazide | 120 | $437 | $4 |
| Sotalol | 15 | $410 | $27 |
| Chlorthalidone | 14 | $396 | $28 |
| Losartan-Hydrochlorothiazide | 30 | $384 | $13 |
| Simvastatin | 56 | $371 | $7 |
| Levothyroxine | 15 | $321 | $21 |
| Amlodipine Besylate | 49 | $271 | $6 |
| Benazepril | 30 | $261 | $9 |
| Ramipril | 16 | $248 | $16 |
| Spironolactone | 16 | $179 | $11 |
2015: 35 drugs
| Crestor | 61 | $20,863 | $342 |
| Xarelto | 30 | $9,864 | $329 |
| Pradaxa | 23 | $9,309 | $405 |
| Metoprolol | 229 | $8,707 | $38 |
| Effient | 16 | $5,180 | $324 |
| Atorvastatin | 224 | $4,089 | $18 |
| Omega-3 Acid Ethyl Esters | 15 | $2,851 | $190 |
| Nifedipine Er | 99 | $2,676 | $27 |
| Digox | 65 | $2,224 | $34 |
| Digoxin | 44 | $1,839 | $42 |
| Clopidogrel | 77 | $1,770 | $23 |
| Warfarin | 95 | $1,760 | $19 |
| Potassium Chloride | 36 | $1,169 | $32 |
| Isosorbide Mononitrate Er | 69 | $1,136 | $16 |
| Losartan | 118 | $1,057 | $9 |
| Metoprolol | 181 | $1,041 | $6 |
| Digitek | 17 | $1,022 | $60 |
| Nifedical Xl | 32 | $992 | $31 |
| Toprol Xl | 12 | $834 | $69 |
| Valsartan | 15 | $808 | $54 |
| Lisinopril | 142 | $758 | $5 |
| Carvedilol | 85 | $754 | $9 |
| Furosemide | 143 | $693 | $5 |
| Enalapril Maleate | 12 | $606 | $50 |
| Hydrochlorothiazide | 111 | $580 | $5 |
| Levothyroxine | 28 | $544 | $19 |
| Simvastatin | 71 | $452 | $6 |
| Nitrostat | 25 | $438 | $18 |
| Valsartan-Hydrochlorothiazide | 18 | $410 | $23 |
| Amlodipine Besylate | 73 | $371 | $5 |
| Losartan-Hydrochlorothiazide | 25 | $356 | $14 |
| Spironolactone | 18 | $165 | $9 |
| Ramipril | 16 | $154 | $10 |
| Amiodarone | 13 | $136 | $10 |
| Benazepril | 18 | $121 | $7 |
2014: 38 drugs
| Crestor | 95 | $24,309 | $256 |
| Metoprolol | 294 | $11,657 | $40 |
| Pradaxa | 30 | $9,907 | $330 |
| Xarelto | 32 | $9,280 | $290 |
| Ranexa | 19 | $7,305 | $384 |
| Zetia | 20 | $6,398 | $320 |
| Atorvastatin | 261 | $5,589 | $21 |
| Diovan | 25 | $4,414 | $177 |
| Lovaza | 17 | $2,792 | $164 |
| Nifedipine Er | 95 | $2,757 | $29 |
| Digoxin | 40 | $2,352 | $59 |
| Digox | 52 | $2,007 | $39 |
| Isosorbide Mononitrate Er | 103 | $1,801 | $17 |
| Clopidogrel | 78 | $1,567 | $20 |
| Warfarin | 91 | $1,365 | $15 |
| Metoprolol | 207 | $1,364 | $7 |
| Losartan | 87 | $1,324 | $15 |
| Nifedical Xl | 53 | $1,290 | $24 |
| Valsartan-Hydrochlorothiazide | 11 | $1,275 | $116 |
| Lisinopril | 189 | $1,174 | $6 |
| Eplerenone | 13 | $1,157 | $89 |
| Carvedilol | 121 | $1,117 | $9 |
| Toprol Xl | 13 | $968 | $74 |
| Amlodipine Besylate | 124 | $832 | $7 |
| Simvastatin | 75 | $830 | $11 |
| Hydrochlorothiazide | 153 | $758 | $5 |
| Furosemide | 144 | $736 | $5 |
| Potassium Chloride | 22 | $666 | $30 |
| Pravastatin | 16 | $557 | $35 |
| Klor-Con 10 | 22 | $553 | $25 |
| Ramipril | 33 | $519 | $16 |
| Levothyroxine | 37 | $491 | $13 |
| Nitrostat | 24 | $489 | $20 |
| Amiodarone | 11 | $416 | $38 |
| Losartan-Hydrochlorothiazide | 28 | $397 | $14 |
| Lisinopril-Hydrochlorothiazide | 30 | $216 | $7 |
| Spironolactone | 21 | $190 | $9 |
| Benazepril | 23 | $132 | $6 |
2013: 39 drugs
| Crestor | 111 | $24,076 | $217 |
| Metoprolol | 347 | $14,809 | $43 |
| Diovan | 61 | $10,715 | $176 |
| Pradaxa | 33 | $10,157 | $308 |
| Atorvastatin | 189 | $6,552 | $35 |
| Niaspan | 14 | $5,174 | $370 |
| Lovaza | 28 | $4,856 | $173 |
| Zetia | 18 | $4,536 | $252 |
| Clopidogrel | 65 | $4,229 | $65 |
| Xarelto | 15 | $3,974 | $265 |
| Nifedipine Er | 128 | $3,747 | $29 |
| Ranexa | 12 | $3,529 | $294 |
| Valsartan-Hydrochlorothiazide | 15 | $2,697 | $180 |
| Nifedical Xl | 56 | $1,911 | $34 |
| Isosorbide Mononitrate Er | 76 | $1,723 | $23 |
| Metoprolol | 166 | $1,424 | $9 |
| Losartan | 66 | $1,420 | $22 |
| Lisinopril | 203 | $1,397 | $7 |
| Warfarin | 80 | $1,340 | $17 |
| Carvedilol | 106 | $1,291 | $12 |
| Eplerenone | 12 | $1,059 | $88 |
| Simvastatin | 108 | $1,018 | $9 |
| Amlodipine Besylate | 106 | $981 | $9 |
| Hydrochlorothiazide | 125 | $796 | $6 |
| Digox | 54 | $750 | $14 |
| Klor-Con 10 | 18 | $568 | $32 |
| Nitrostat | 19 | $421 | $22 |
| Losartan-Hydrochlorothiazide | 20 | $419 | $21 |
| Furosemide | 106 | $410 | $4 |
| Lisinopril-Hydrochlorothiazide | 36 | $350 | $10 |
| Benazepril | 28 | $349 | $12 |
| Spironolactone | 27 | $323 | $12 |
| Digoxin | 17 | $285 | $17 |
| Levothyroxine | 28 | $260 | $9 |
| Ramipril | 20 | $249 | $12 |
| Diltiazem 24hr Er | 11 | $202 | $18 |
| Clonidine | 14 | $171 | $12 |
| Isosorbide Dinitrate | 13 | $81 | $6 |
| Bumetanide | 12 | $80 | $7 |
Money from drug and device companies
$132 in 2025
| 2025 | 1 | 2 | None | $132 |
| 2024 | 4 | 5 | None | $78 |
| 2023 | 7 | 16 | None | $418 |
| 2022 | 8 | 13 | $1,000 | $1,250 |
| 2021 | 6 | 8 | $2,000 | $2,130 |
| 2020 | 2 | 4 | $2,000 | $2,025 |
| 2019 | 4 | 6 | None | $201 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Corevalve Evolut R | $132 | 2 payments
|
See all 2 published payments
| Medtronic | Meals · 2025-08-06 | Azure Xt Dr Mri Surescan | $16 |
| Medtronic | Meals · 2025-04-28 | Corevalve Evolut R | $116 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $78
| Amgen | Repatha | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $22 | 1 payment
|
| Novo Nordisk | None | $18 | 1 payment
|
| Medtronic | Azure Xt Dr Mri Surescan | $15 | 1 payment
|
2023: $418
| Abiomed | Impella | $131 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $77 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $68 | 4 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $61 | 2 payments
|
| Abbott Laboratories | Optis | $45 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $19 | 1 payment
|
| Novo Nordisk | None | $16 | 1 payment
|
2022: $1,250
| Abbott Laboratories | Portico | $1,000 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $113 | 5 payments
|
| Novartis Pharmaceuticals | Leqvio | $44 | 2 payments
|
| Pfizer | Vyndaqel | $23 | 1 payment
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $21 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $17 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $16 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
2021: $2,130
| Abbott Laboratories | Xience V Coronary Stent System | $2,000 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $39 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $32 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $21 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
2020: $2,025
| Abbott Laboratories | Xience V Coronary Stent System | $2,000 | 2 payments
|
| Medtronic Vascular | Azure | $25 | 2 payments
|
2019: $201
| Abiomed | Impella | $103 | 1 payment
|
| Amgen | Repatha | $62 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $24 | 2 payments
|
| Chiesi USA | Kengreal | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Medtronic Vascular, Inc. · Spyral Htn-Off Med · 2020 | Their institution | $4,250 |
| Medtronic Vascular, Inc. · Onyx One · 2019 | Their institution | $3,000 |
| Medtronic, Inc. · Spyral Htn-on Med · 2021 | Their institution | $2,250 |
| Medtronic Vascular, Inc. · Onyx One Clear · 2020 | Their institution | $2,000 |
| Medtronic Vascular, Inc. · Spyral Htn-on Med · 2019 | Their institution | $1,500 |
| Medtronic Vascular, Inc. · Onyx One Clear · 2019 | Their institution | $1,000 |
| Medtronic, Inc. · Spyral Htn-on Med · 2023 | Their institution | $1,000 |
| Medtronic, Inc. · Spyral Dystal · 2023 | Their institution | $1,000 |
| Medtronic, Inc. · Spyral Dystal · 2022 | Their institution | $1,000 |
| Medtronic, Inc. · Spyral Htn-on Med · 2022 | Their institution | $1,000 |
Professional record
- NPI
- 1598795429
- Licence
- CA G87536California G87536: Current · expires 2028-09-30
- Group
- Central California Faculty Medical Group Inc · Fresno Community Hospital and Medical Center
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA OOG875360
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2625 E Divisadero St, Fresno, CA, 93721
- NPI first listed
- 2006-07-04
- NPI last updated
- 2024-12-23
- NPI record certified
- 2024-12-23
This is when the NPI record was last certified, not a medical board exam.